| Clinical and economic impact of medication reconciliation in cancer patients: a systematic review C Herledan, A Baudouin, V Larbre, A Gahbiche, E Dufay, I Alquier, ... Supportive Care in Cancer 28, 3557-3569, 2020 | 33 | 2020 |
| Real-life drug–drug and herb–drug interactions in outpatients taking oral anticancer drugs: Comparison with databases H Prely, C Herledan, AG Caffin, A Baudouin, V Larbre, M Maire, ... Journal of Cancer Research and Clinical Oncology 148 (3), 707-718, 2022 | 31 | 2022 |
| Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study V Leclerc, L Karlin, C Herledan, L Marchal, A Baudouin, A Gouraud, ... Journal of Cancer Research and Clinical Oncology 148 (4), 975-984, 2022 | 15 | 2022 |
| Impact of pharmaceutical care interventions on multidisciplinary care of older patients with cancer: A systematic review C Herledan, MA Cerfon, A Baudouin, V Larbre, C Lattard, N Poletto, ... Journal of Geriatric Oncology 14 (4), 101450, 2023 | 13 | 2023 |
| Immunosuppression medication adherence after allogeneic hematopoietic stem cell transplant: Impact of a specialized clinical pharmacy program F Charra, M Philippe, C Herledan, AG Caffin, V Larbre, A Baudouin, ... Journal of oncology pharmacy practice, 10781552211000115, 2021 | 10 | 2021 |
| Economic impact of clinical pharmaceutical activities in hospital wards: a systematic review A Baudouin, C Herledan, N Poletto, MD Guillemin, O Maison, R Garreau, ... Research in Social and Administrative Pharmacy 17 (3), 497-505, 2021 | 9 | 2021 |
| Drug cost savings in phase III hematological oncology clinical trials in a university hospital C Herledan, F Ranchon, V Schwiertz, A Baudouin, L Karlin, ... Hematological oncology 38 (4), 576-583, 2020 | 7 | 2020 |
| Enhancing collaboration between geriatricians, oncologists, and pharmacists to optimize medication therapy in older adults with cancer: A position paper from SOFOG-SFPO C Herledan, A Toulemonde, AL Clairet, M Boulin, C Falandry, ... Critical Reviews in Oncology/Hematology, 104117, 2023 | 4 | 2023 |
| Medication assessment in older adults with cancer–current practices in clinical pharmacy DJ Walsh, K Kantilal, C Herledan, G Nightingale, V Slavova-Boneva, ... J Geriatr Oncol 14, 101531, 2023 | 4 | 2023 |
| Assessment of patient reported outcomes (pros) in outpatients taking oral anticancer drugs included in the real-life Oncoral program B Collomb, A Dubromel, AG Caffin, C Herledan, V Larbre, A Baudouin, ... Cancers 14 (3), 660, 2022 | 4 | 2022 |
| Introduction du PICC-Line au sein d’un centre hospitalo-universitaire: bilan après deux ans d’expérience C Serrano, J Bataille, C Herledan, A Rieutord, AS Dumenil, VF Derouin J Pharm Clin 35 (1), 35-46, 2016 | 4 | 2016 |
| Clinical and economic impact of clinical oncology pharmacy in cancer patients receiving injectable anticancer treatments: A systematic review C Lattard, A Baudouin, V Larbre, C Herledan, A Cerutti, MA Cerfon, ... Journal of Cancer Research and Clinical Oncology 149 (10), 7905-7924, 2023 | 3 | 2023 |
| Clinical impact and cost‐saving analysis of a comprehensive pharmaceutical care intervention in older patients with cancer C Herledan, C Falandry, L Huot, N Poletto, A Baudouin, MA Cerfon, ... Journal of the American Geriatrics Society 72 (2), 567-578, 2024 | 2 | 2024 |
| Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients’ knowledge to manage adverse effects J Perichou, F Ranchon, C Herledan, L Huot, V Larbre, I Carpentier, ... Plos one 15 (12), e0243309, 2020 | 2 | 2020 |
| Medication reconciliation and review to prevent medication errors in elderly cancer patients C Herledan, A Baudouin, M Tracol, R Garreau, N Poletto, F Ranchon, ... Journal of Geriatric Oncology 10 (6), S57-S58, 2019 | 2 | 2019 |
| Real-world experience with CDK4-6 inhibition in the old and oldest old with a diagnosis of breast cancer P Sobrini-Morillo, C Ravot, C Herlédan, C Sánchez-Castellano, ... Seminars in Oncology, 2024 | 1 | 2024 |
| Preparations of exploration of immediate hypersensitivity to antineoplastic agents: An oncology pharmacy perspective A Dubromel, AG Caffin, F Hacard, N Vantard, A Baudouin, C Herledan, ... Journal of oncology pharmacy practice: official publication of the …, 0 | 1 | |
| Feasibility of a screening and prevention procedure for risks associated with dysphagia in older patients in geriatric units: the DYSPHAGING pilot study protocol O Durlach, S Tripoz-dit-Masson, N Massé-Deragon, F Subtil, Z Niasse-Sy, ... BMJ open 14 (4), e081333, 2024 | | 2024 |
| Cost-effectiveness of the ONCORAL multidisciplinary programme for the management of outpatients taking oral anticancer agents at risk of drug-related event: protocol for a … L Huot, P Guerre, G Descotes, AG Caffin, C Herledan, F Ranchon, ... BMJ open 14 (2), e074956, 2024 | | 2024 |
| A global perspective of medication reviews by pharmacists in geriatric oncology clinics K Kantilal, D Walsh, C Herledan, G Nightingale, V Slavova-Boneva, ... Journal of Geriatric Oncology 14 (8), S33, 2023 | | 2023 |
